What I Wasn’t Told About Prostate Cancer Treatments
The author writes about his personal treatment for prostate cancer and what he wished he had known beforehand. Read the article.
What I Wasn’t Told About Prostate Cancer Treatments Read More »
Patterns of care and treatment trends for Canadian men with localized low-risk prostate cancer: an analysis of provincial cancer registry data.
The provinces vary substantially with respect to the types of primary treatment received by men with localized low-risk pca. From 2010 to 2013, many men had no record of surgical or radiation treatment within 1 year of diagnosis-a proxy for active surveillance; the proportion ranged from 53.3% in Nova Scotia to 80.8% in New Brunswick. Among men who did receive primary treatment, the use of radical prostatectomy ranged from 12.0% in New Brunswick to 35.9% in Nova Scotia. The use of radiation therapy (external-beam radiation therapy or brachytherapy) ranged from 4.1% in Newfoundland and Labrador to 17.6% in Alberta. Treatment
Aggressive Prostate Cancer Appears to be Linked to Self-Renewing Stem Cells Within the Prostate
University of Texas MD Anderson Cancer Center researchers have demonstrated that the prostate basal cell layer contains self-renewing adult stem cells, with a gene expression profile that overlaps that of aggressive and endocrine therapy-resistant prostate cancers. These results indicate that such cells might be the cells-of-origin in aggressive prostate cancers, and offer a new option for anticancer therapies. Read the article.
Video: “A twenty year personal reflection on the privilege of caring for men with prostate cancer”
May 2016 Awareness Night A twenty year personal reflection on the privilege of caring for men with prostate cancer Dr. Rajiv Singal, MD, FRCSC Endourology, Urologic Cancer and Robotic Surgery Michael Garron Hospital Asst. Prof., Dept. of Surgery, U. of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 39:36 minutes
HIFU in UK
Keep your pecker up, Bill…new prostate cancer zapper won’t wreck your love life! Pioneering soundwave treatment proves as effective as surgery. • High-intensity focused ultrasound blasts tumours with soundwaves • Study shows its 93 per cent success rate as effective as surgery • But rate of erectile dysfunction in HIFU patients post treatment much lower • ‘Experimental’ treatment not widely available in UK and costs £10,000 Read the article.
Blood Tests Can Predict How Aggressive Prostate Cancer Is, Study Says
A new study is suggesting that a blood test for examining sex hormone levels can predict how aggressive prostate cancer is in a patient. Read the article.
Blood Tests Can Predict How Aggressive Prostate Cancer Is, Study Says Read More »
New advances in salvage brachytherapy
Calgary Tom Baker Cancer Centre radiation oncologist Dr. Siraj Husain discusses advances and new studies in the growing area of Salvage Brachytherapy. He starts with a quick but informative overview of prostate cancer, its diagnosis and treatments, and then launches into studies with graphic slides that show the groundbreaking work that is being done today in the field. Very informative, and the future looks very bright in the field of prostate cancer treatment. A lively discussion follows, including talk about the whole PSA debate. Watch the video.
New advances in salvage brachytherapy Read More »
Information Is Key for Men With Prostate Cancer
The treatment options for men with prostate cancer are constantly evolving, adding further stress to an already challenging decision. Before receiving treatment, men should receive a second opinion and fully understand their options, according to Jim Schraidt, a prostate cancer survivor from Chicago who leads a support group for Us TOO International. Read the article.
Information Is Key for Men With Prostate Cancer Read More »
Aggressive Prostate Cancers Appear to Be Linked to Self-Renewing Stem Cells
University of Texas MD Anderson Cancer Center researchers have demonstrated that the prostate basal cell layer contains self-renewing adult stem cells, with a gene expression profile that overlaps that of aggressive and endocrine therapy-resistant prostate cancers. These results indicate that such cells might be the cells-of-origin in aggressive prostate cancers, and offer a new option for anticancer therapies. Read the article.
Aggressive Prostate Cancers Appear to Be Linked to Self-Renewing Stem Cells Read More »
Prostate cancer vaccine trial begins at Oxford and Sheffield
Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just been opened at the Royal Hallamshire Hospital in Sheffield. Read the article.
Prostate cancer vaccine trial begins at Oxford and Sheffield Read More »